Evidence map›Paper›PMID 33478278›Full record

ArticleLeukemia & lymphoma2021

Esther Sathya Bama Benjamin, Niveditha Ravindra, Bharathi Murugan Rajamani, Senthamizhselvi Anandan, Bagavathi Kausalya, Vidya Veldore, Vikram Mathews, Shaji Ramachandran Velayudhan, Poonkuzhali Balasubramanian

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia & lymphoma, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Applications of Next Generation Sequencing in Haematological Disorders-Indian Status: Updates from ISHBT 2018.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Esther Sathya Bama BenjaminDepartment of Hematology, Christian Medical College, Vellore, India.
Niveditha RavindraDepartment of Hematology, Christian Medical College, Vellore, India.
Bharathi Murugan RajamaniDepartment of Hematology, Christian Medical College, Vellore, India.
Senthamizhselvi AnandanDepartment of Hematology, Christian Medical College, Vellore, India.
Bagavathi KausalyaMedGenome Labs Ltd, Bengaluru, India.
Vidya VeldoreMedGenome Labs Ltd, Bengaluru, India.
Vikram MathewsDepartment of Hematology, Christian Medical College, Vellore, India.
Shaji Ramachandran Velayudhan
Poonkuzhali BalasubramanianDepartment of Hematology, Christian Medical College, Vellore, India.
Christian Medical College & Hospital · INSciGenom Labs (India) · IN

Funding

DBT-Wellcome Trust India Alliance IA/CPHS/18/1/503930DBT-Wellcome Trust India Alliance IA/S/15/1/501842DBT-Wellcome Trust India Alliance IA/S/17/1/503118Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

High-Throughput Nucleotide SequencingLeukemia, Myelogenous, Chronic, BCR-ABL PositiveDrug Resistance, NeoplasmFusion Proteins, bcr-ablHumansImatinib MesylateMutationProtein Kinase InhibitorsFusion Proteins, bcr-ablImatinib MesylateProtein Kinase Inhibitors

Identifiers

PMID33478278
PMCPMC7611165
OpenAlexW3121963877

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.